Nigerian breast cancer survivor speaks out against stigma that delays treatment

Date:

Gloria Chinyere Okwu, a Nigerian woman who survived breast cancer, has chosen to publicly share her experience in an effort to challenge the silence and stigma surrounding the disease in Nigeria, where delayed diagnosis and social taboos contribute to some of the highest mortality rates in the world.

Okwu described being told by a doctor that she likely had breast cancer and that a mastectomy would be necessary. She said the diagnosis came after months of dismissing symptoms and seeking care in a system where many women are discouraged from discussing breast health openly.

“I was told to keep my diagnosis private,” Okwu wrote in an essay published by The Guardian. “But I am determined to show the reality of breast cancer and reject the stigma that prevents women from seeking treatment.”

Breast cancer is the leading cause of cancer death among women in Nigeria, according to the World Health Organization. The five-year survival rate in Nigeria is approximately 20%, compared to over 90% in high-income countries, largely due to late-stage presentations and limited access to screening and treatment.

Okwu underwent chemotherapy and surgery, documenting her journey to encourage other women to seek early care. She said the shame and secrecy around the disease often prevent women from coming forward until it is too late.

“My scars are not something to hide,” she said. “They are proof that I fought and won.”

Her story reflects broader challenges in Nigeria’s healthcare system, where cultural stigma, lack of awareness, and inadequate infrastructure compound the burden of cancer care.

Analysis: Okwu’s decision to speak publicly aligns with advocacy efforts by Nigerian health organizations to normalize conversations about breast cancer. Experts say community engagement and education are critical to improving early detection rates. However, systemic issues such as underfunded oncology services and limited screening programs continue to hinder progress.

Sources:
https://www.theguardian.com/global-development/2026/sep/02/nigerian-women-breast-cancer-stigma-chemotherapy-nigeria-mortality-rate

Source: Guardian International

Corrections

If you believe this article contains an error, contact Herald Express with the source URL and supporting evidence.

Story synopsis gathered from: Guardian International — source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Share post:

Subscribe

Popular

More like this
Related

UK Competition Regulator Proposes Opening Apple iPhone Contactless Technology to Local Fintechs

The UK Competition and Markets Authority announced proposals on October 20, 2026, aimed at opening access to Near Field Communication technology on Apple iPhones, seeking to allow financial technology companies and other businesses to offer competing contactless services. According to…

BJP Retains Control of Gandhinagar Municipal Corporation With 38 Seats

The Bharatiya Janata Party secured 38 out of 44 seats in the Gandhinagar Municipal Corporation elections in Gujarat, retaining its administrative hold over the state capital's civic body. According to election data, voter turnout reached 59.25% among the municipal corporation's…

600,000 UK Families Boost Savings with Tax‑Free Childcare Scheme

More than 600,000 UK families used Tax-Free Childcare in June 2026, receiving GBP 55.7 million in government top-ups, according to official figures.

Justice Department Charges 16 Individuals in Federal Election Crime Sweep

The U.S. Department of Justice announced criminal charges against 16 individuals across the country involving allegations of illegal voting, fraudulent voter registration, and related election offenses, according to a press release issued on Oct. 12, 2026. The nationwide charges encompass…